Yifan He
Overview
Explore the profile of Yifan He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
979
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dang Z, He Y, Xie R, Chen P, Dong F
J Ren Nutr
. 2025 Mar;
PMID: 40081608
Objective: We aimed to perform a systematic review and meta-analyses to evaluate the impact of plant-based diet (PBD) on chronic kidney disease (CKD). Methods: A systematic search of PubMed and...
2.
Han Y, Li X, Song W, He Y
Front Psychol
. 2025 Mar;
16:1490363.
PMID: 40070905
Introduction: This study investigates the association between young adult partner phubbing and relationship satisfaction, with a focus on the mediating role of attachment anxiety and the moderating role of constructive...
3.
Gao J, He Y, Shi F, Hou F, Wu X, Yi Y, et al.
J Adv Res
. 2025 Mar;
PMID: 40037430
Background: Sirt6-mediated gut microbiota plays a vital role in poststroke depression (PSD). Icariside Ⅱ (ICS Ⅱ) is a naturally-occurring neuroprotectant with Sirt6 induction potency. However, it is unknown whether ICS...
4.
He Y, Xu L, Pei X, Dong Y, Yang X
Curr Pharm Biotechnol
. 2025 Feb;
PMID: 39995124
Introduction: The use of polydeoxyribonucleotide (PDRN) in promoting tissue repair and anti-aging has been hindered by several challenges, including its large molecular weight, susceptibility to decomposition, low bioavailability, and poor...
5.
Roy D, He Y, Wang Y, Xu P, Jin B, Xiao H, et al.
Sci Rep
. 2025 Feb;
15(1):6015.
PMID: 39971962
AGR2 is a pro-oncogenic protein overexpressed in multiple cancer types, and it promotes tumor progression. Therefore, it is regarded as a promising therapeutic target for cancer. We reported the development...
6.
He H, Li J, Meng H, He Y, Pei X, Zhang Z
Curr Pharm Des
. 2025 Feb;
PMID: 39950457
Nanoemulsions have gained popularity as drug delivery vehicles owing to the enhanced solubility of insoluble drugs, the augmented stability of photo- and thermosensitive substances, and the facilitation of transdermal permeation...
7.
He Q, Wang J, Shi R, He Y, Wu M
Sci Rep
. 2025 Feb;
15(1):5376.
PMID: 39948163
No abstract available.
8.
Xue W, Aung A, Guerrero-Cruz S, Xiao K, He Y, Anal A, et al.
Water Res
. 2025 Jan;
275:123199.
PMID: 39889440
Waste activated sludge (WAS) management presents significant challenges due to its complex composition and the high cost associated with conventional treatment methods. This study investigates the potential of osmotic microbial...
9.
Fu Y, He Y, Wu D, Sui B, Jin Y, Hu X, et al.
Life Med
. 2025 Jan;
2(2):lnad013.
PMID: 39872110
Apoptosis represents the dominant form of programmed cell death and plays critical roles in maintaining tissue and organ homeostasis. A notable population of extracellular vesicles (EVs) is generated during apoptosis,...
10.
He Y, Czaplicki Cabezas S, Maillard O, Muller R, Romero-Munoz A, Romero Pimentel L, et al.
Science
. 2025 Jan;
387(6731):255.
PMID: 39818878
No abstract available.